دورية أكاديمية
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting
العنوان: | Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting |
---|---|
المؤلفون: | Garg, Mahek, Puckett, Justin, Kamal-Bahl, Sachin, Raut, Monika, Ryland, Katherine Elizabeth, Doshi, Jalpa A., Huntington, Scott F. |
المساهمون: | Merck & Co Inc |
المصدر: | Clinical Lymphoma Myeloma and Leukemia ; ISSN 2152-2650 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2024 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
مصطلحات موضوعية: | Cancer Research, Oncology, Hematology |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.clml.2024.01.010 |
الإتاحة: | https://doi.org/10.1016/j.clml.2024.01.010Test https://api.elsevier.com/content/article/PII:S2152265024000545?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2152265024000545?httpAccept=text/plainTest |
حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/ |
رقم الانضمام: | edsbas.CC259FDE |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.clml.2024.01.010 |
---|